Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Nimesulida

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 16Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Global Drug Regulation Lessons From Nimesulide On Patient Safety
    Global Drug Regulation Lessons From Nimesulide On Patient Safety

    09 Jan 2026

    // EXPRESSPHARMA

    https://www.expresspharma.in/nimesulide-and-patient-safety-lessons-from-global-drug-regulation/

    EXPRESSPHARMA
    09 Jan 2026
    Share Share
    Haryana & Telangana Crack Down On Nimesulide Over 100 Mg
    Haryana & Telangana Crack Down On Nimesulide Over 100 Mg

    03 Jan 2026

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=183349&sid=1

    PHARMABIZ
    03 Jan 2026
    Share Share
    Government Bans Nimesulide Oral Formulations Above 100 mg
    Government Bans Nimesulide Oral Formulations Above 100 mg

    31 Dec 2025

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/nimesulide-ban-govt-puts-a-stop-to-manufacture-sale-of-all-oral-formulations-containing-the-popular-painkiller-above-100-mg/articleshow/126263183.cms

    ECONOMICTIMES
    31 Dec 2025
    Share Share
    Nimesulide May Include Warning Label
    Nimesulide May Include Warning Label

    16 Sep 2025

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/nimesulide-may-come-with-warning-label/articleshow/123928117.cms

    ECONOMICTIMES
    16 Sep 2025
    Share Share
    ICMR for selective ban on popular painkiller
    ICMR for selective ban on popular painkiller

    23 Apr 2025

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/icmr-for-selective-ban-on-popular-painkiller/articleshow/120529282.cms

    ECONOMICTIMES
    23 Apr 2025
    Share Share
    Helsinn and Angelini Pharma renew distribution deal
    Helsinn and Angelini Pharma renew distribution deal

    28 May 2024

    // PHARMACEUTICAL TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/helsinn-angelini-distribution-deal/

    PHARMACEUTICAL TECHNOLOGY
    28 May 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.